Skip to main content

Table 1 Patient baseline characteristics (N = 62)

From: Tele-monitoring reduces exacerbation of COPD in the context of climate change–a randomized controlled trial

Group TG CG P-Value
N 32 30  
Gender (male/female) 26/6 22/8 .79
Age (years) 64.1 ± 10.9 69.1 ± 9.2 .27
BMI (kg/m 2 ) 27.6 ± 6.7 27.0 ± 4.9 .87
Resting SpO 2 Saturation 95.4 ± 1.7 94.3 ± 3.6 .095
FEV 1 (%) 50.2 ± 15.0 52.6 ± 17.5 .731
PEF (L/min) 3.7 ± 1.23 4.4 ± 1.4 .194
MMRC 1.9 ± 1.1 1.2 ± 0.93 .125
GOLD 2.6 ± 0.8 2.5 ± 0.9 .83
BODE 3.2 ± 3.1 2.9 ± 3.0 .55
SGRQ 51.3 ± 18.7 48.7 ± 14.7 .56
COPD Medication    
Long AC 25 (78%) 22 (73%) .33
ICS/LABA 23 (72%) 21 (70%) .46
  1. Characteristics of patient population; data is presented as Mean ± SD; group comparisons of measurements across between Tele-monitoring group (TG) and control group (CG) were done using a two tailed student’s t-test and χ2-test. BMI = Body Mass Index; SpO2 = resting oxygen saturation; FEV1 (L) = Forced Expiratory Volume in one second; PEF = Peak Expiratory Flow; MMRC = Modified Medical Research Council Dyspnea Scale; SGRQ = St. George Respiratory Questionnaire; Long AC = Long Acting Anticholinergic; ICS/LABA = fix combination of ICS/LABA.